TRIM27 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.117000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.013200E-01
Normal-vs-Stage2
4.327400E-01
Normal-vs-Stage3
6.013900E-02
Normal-vs-Stage4
5.864600E-01
Stage1-vs-Stage2
4.987000E-01
Stage1-vs-Stage3
6.420400E-02
Stage1-vs-Stage4
8.549200E-01
Stage2-vs-Stage3
3.787900E-02
Stage2-vs-Stage4
7.274600E-01
Stage3-vs-Stage4
5.590200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.221600E-01
Normal-vs-AfricanAmerican
3.459800E-01
Normal-vs-Asian
6.720600E-01
Caucasian-vs-AfricanAmerican
8.713400E-01
Caucasian-vs-Asian
4.675400E-01
AfricanAmerican-vs-Asian
5.039200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.855200E-01
Normal-vs-Female
1.913170E-01
Male-vs-Female
9.725500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.007000E-01
Normal-vs-Age(41-60Yrs)
3.980400E-01
Normal-vs-Age(61-80Yrs)
3.962800E-01
Normal-vs-Age(81-100Yrs)
7.776800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.619800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.970600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.445000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.777600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.248600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.714600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.269000E-01
Normal-vs-Daily Drinker
8.374300E-02
Normal-vs-Weekly Drinker
6.172400E-01
Normal-vs-Occasional Drinker
8.497000E-01
Normal-vs-Social Drinker
3.357400E-01
Non Drinker-vs-Daily Drinker
2.474800E-01
Non Drinker-vs-Weekly Drinker
4.035000E-01
Non Drinker-vs-Occasional Drinker
2.163200E-01
Non Drinker-vs-Social Drinker
9.501400E-01
Daily Drinker-vs-Weekly Drinker
2.991900E-02
Daily Drinker-vs-Occasional Drinker
1.524100E-02
Daily Drinker-vs-Social Drinker
2.050400E-01
Weekly Drinker-vs-Occasional Drinker
7.033400E-01
Weekly Drinker-vs-Social Drinker
3.960400E-01
Occasional Drinker-vs-Social Drinker
2.538600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.790200E-01
Normal-vs-Grade 2
1.954640E-01
Normal-vs-Grade 3
2.126600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.152800E-01
Grade 1-vs-Grade 3
9.392200E-01
Grade 1-vs-Grade 4
2.790200E-01
Grade 2-vs-Grade 3
4.893400E-01
Grade 2-vs-Grade 4
1.954640E-01
Grade 3-vs-Grade 4
2.126600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.883200E-01
Normal-vs-NonDiabetic
2.722200E-01
Diabetic-vs-NonDiabetic
6.877800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.372200E-01
Normal-vs-NoPancreatitis
4.126400E-01
Pancreatitis-vs-NoPancreatitis
6.717000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.003000E-01
Normal-vs-N1
3.308800E-01
N0-vs-N1
1.732400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.967800E-01
Normal-vs-TP53-NonMutant
8.691600E-01
TP53-Mutant-vs-TP53-NonMutant
3.078000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
